Atara Biotherapeutics (ATRA) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

ATRA Atara Biotherapeutics

Watchlist

11.470
+0.860+8.11%

Close Nov 22 16:00 ET

11.470
0.0000.00%

Post 20:02 ET

66.06MMarket Cap-453P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Insider Sale: EVP of $ATRA (ATRA) Sells 1,000 Shares
Quiver QuantitativeNov 20 18:16 ET
Atara Biotherapeutics to Participate at the Stifel 2024 Healthcare Conference
BusinesswireNov 13 16:01 ET
CCORF Maintains Atara Biotherapeutics(ATRA.US) With Buy Rating, Raises Target Price to $21
Moomoo NewsNov 13 08:31 ET · Ratings
Atara Biotherapeutics Price Target Raised to $21 From $13 at Canaccord
TipRanksNov 13 07:51 ET
Atara Biotherapeutics Advances With Strategic Partnerships
TipRanksNov 12 16:45 ET
Atara Biotherapeutics | 8-K: Atara Biotherapeutics Announces Third Quarter 2024 Financial Results and Operational Progress
SECNov 12 16:42 ET

Comments

Stock_Drift

Nov 15 16:17

After Hours Ticks. 5:16pm 11/15🦌

$Scorpius Holdings (SCPX.US)$ $Perspective Therapeutics (CATX.US)$ $Turbo Energy (TURB.US)$ $Adverum Biotechnologies (ADVM.US)$ $NFT Ltd (MI.US)$ $Xylo Technologies (XYLO.US)$ $Lipocine (LPCN.US)$ $Massimo (MAMO.US)$ $China Jo-Jo Drugstores (CJJD.US)$ $Edesa Biotech (EDSA.US)$ $Atara Biotherapeutics (ATRA.US)$ $Eterna Therapeutics (ERNA.US)$ $DDC Enterprise (DDC.US)$
📊⚡️📊

joeyboulevard

Nov 5 07:16

$Atara Biotherapeutics (ATRA.US)$ Looks good!

Jaguar8

Sep 5 15:19

Atara Biotherapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Adiumentum Capital Fund I LP(19.99%),Adiumentum Capital Fund I GP LLC(19.99%), etc.

$Atara Biotherapeutics (ATRA.US)$

FattyChick

Sep 5 08:15

$Atara Biotherapeutics (ATRA.US)$ Should have a re-entry at 7.70

rmgm

Sep 4 08:19

$Atara Biotherapeutics (ATRA.US)$ over 30 million cash in the books acccording to there 30th of June Financial report , will have additional extra cash of 36 million on 5 September from institutional investors and big pharma company by issuing them around 4 million shares at 8.25 $ , will further receive 20 million + 60 Million by Pierre Fabre Pharmaceuticals once FDA approves there EBV drug in Jan 2025 .
Should see increased acitivity soon as all these large investors have interest in this comp...

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

ATRA Atara Biotherapeutics

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target